Crystal Murray Holmes, DPM, CWSP
Clinical Professor of Internal Medicine
Medical Director
Podiatry Program
Metabolism
Endocrinology and Diabetes
Internal Medicine, Division of Metabolism, Endocrinology and Diabetes
Domino's Farms, 24 Frank Lloyd Wright Dr., Lobby C
Ann Arbor, MI 48106

Available to mentor
Crystal Murray Holmes, DPM, CWSP
Clinical Professor
  • About
  • Links
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
    • About

    Dr. Holmes is a Clinical Professor of Internal Medicine in the Division of Metabolism, Endocrinology, and Diabetes (MEND) at the University of Michigan Medical School. After graduating from Kent State College of Podiatric Medicine, Dr. Holmes completed her residency at the University of Texas at San Antonio and joined the University of Michigan in 2006. Dr. Holmes has experience with all aspects of podiatric medicine with special interest in the management of the Diabetic Foot and Wound Care. She is Board Certified with American Board of Podiatric Medicine and is also a Certified Wound Specialist Physician with the American Board of Wound Management.

    Links
    • https://www.uofmhealth.org/profile/1514/crystal-murray-holmes-dpm
    • linkedin
    • https://experts.umich.edu/discover/experts_publication
    • https://pubmed.ncbi.nlm.nih.gov/?term=Holmes%2C crystal
    Qualifications
    • Resident
      University of Texas health Science Center at San Antonio, San Antonio, TX, 2005
    • DPM
      Kent State University College of Podiatric Medicine, Independence, 2002
    • BA
      Fisk University, Nashville, 1997
    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    Research Overview

    Wound care, infection management, diabetic neuropathy, Charcot neuro osteoarthropathy

    Recent Publications See All Publications
    • Journal Article
      Reviewing recommendations from the IWGDF 2023 guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy: highlighting the role of temperature monitoring with illustrative case reports.
      Rothenberg GM, Killeen AL, Holmes C. Wounds, 2024 Jun; 36 (6): 206 - 211. DOI:10.25270/wnds/24029
      PMID: 39018364
    • Journal Article
      The impact of statin therapy on the healing of diabetic foot ulcers: a case-control series.
      O'Dell B, Rothenberg G, Holmes C, Priesand S, Mizokami-Stout K, Brandt EJ, Schmidt BM. Clin Diabetes Endocrinol, 2024 Jul 10; 10 (1): 19 DOI:10.1186/s40842-024-00175-8
      PMID: 38982504
    • Journal Article
      311-OR: High Transepidermal Water Loss (TEWL) Associates with Failure to Maintain Wound Closure in Diabetic Foot Ulcers
      SCHMIDT BM, SPINO C, ROY S, GORDILLO G, HOLMES CM, SEN CK, BUSUI R. Diabetes, 2024 Jun 14; 73 (Supplement_1): DOI:10.2337/db24-311-or
    • Presentation
      "MEND Podiatry Outcomes"
      2024 Mar 16;
    • Presentation
      "Charcot: What We Know and What We Need"
      2023 Dec 9;
    • Journal Article
      151-OR: Social Determinants of Health Predict Diabetic Foot Infection Development
      SCHMIDT BM, BURANT A, BAKER N, KATONA A, MARTIN C, HOLMES CM, BUSUI R. Diabetes, 2023 Jun 20; 72 (Supplement_1): DOI:10.2337/db23-151-or
    • Journal Article
      Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023).
      Wukich DK, Schaper NC, Gooday C, Bal A, Bem R, Chhabra A, Hastings M, Holmes C, Petrova NL, Santini Araujo MG, Senneville E, Raspovic KM. Diabetes Metab Res Rev, 2024 Mar; 40 (3): e3646 DOI:10.1002/dmrr.3646
      PMID: 37218537
    • Journal Article
      Diagnosis and treatment of active charcot neuro-osteoarthropathy in persons with diabetes mellitus: A systematic review.
      Raspovic KM, Schaper NC, Gooday C, Bal A, Bem R, Chhabra A, Hastings M, Holmes C, Petrova NL, Santini Araujo MG, Senneville E, Wukich DK. Diabetes Metab Res Rev, 2024 Mar; 40 (3): e3653 DOI:10.1002/dmrr.3653
      PMID: 37179484